EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Evaluation of Freezing Protocols and Cryopreservation Media for the Preservation of Alginate Encapsulated HepaRG Cells

Carla Meschini iD, Andrea Bartolucci iD, Ulysse Pereira iD

Cells · 2026

DOI: 10.3390/cells15191783 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cells, 2026. Verfasst von Carla Meschini und 2 weiteren Autor:innen. Beteiligte Einrichtung: UMR CNRS, BMBI, Génie Biologique, Université de Technologie de Compiègne, F-60203 Compiègne, France. Hauptthemen laut MEDLINE: Cryopreservation, Alginates, Cryoprotective Agents, Freezing. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Technologie de Compiègne, Inserm, Biopredic (France).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reliable storage and distribution are important for developing ready-to-use encapsulated cell products for transplantation and bioartificial liver applications. This study evaluated the cryopreservation of alginate-encapsulated HepaRG cells using a programmable controlled-rate freezing (CRF) protocol at −0.3 °C/min or conventional passive cooling at approximately −1 °C/min. Five media were tested: four commercial xeno-free formulations, including two DMSO-containing and two DMSO-free media, and a conventional formulation containing 90% fetal bovine serum and 10% DMSO. Following thawing and a 3-day recovery period, metabolic activity, albumin secretion, ammonia and lactate clearance, and phase I and phase II biotransformation activities were assessed. Cryopreservation reduced metabolic activity relative to non-frozen controls, but key hepatic functions remained detectable. The tested CRF protocol generally yielded equal or higher functional values than conventional freezing. Medium performance varied according to the endpoint assessed. Within CRF, CryoStor CS10 produced relatively high mean PrestoBlue and albumin secretion values, whereas Cellvation produced the highest mean CYP1A1/1A2 activity. These product-specific observations do not establish a general effect of DMSO. The findings support the short-term feasibility of the tested CRF protocol for this encapsulated HepaRG model but not broader clinical or drug-testing applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationAlginatesCryoprotective AgentsFreezingHepatocytesHumansGlucuronic AcidHexuronic AcidsDimethyl SulfoxideCell SurvivalAlbuminsCell Line

Stichwörter der Autor:innen

HepaRG cellsalginatecontrolled-rate-freezingcryopreservationcryopreservation solutionhepatocytes

Substanzen

AlginatesCryoprotective AgentsGlucuronic AcidHexuronic AcidsDimethyl SulfoxideAlbumins

Autor:innen und Institutionen

  • UMR CNRS, BMBI, Génie Biologique, Université de Technologie de Compiègne, F-60203 Compiègne, France.
  • University Campus Bio-Medico di Roma, 00128 Rome, Italy.

ORCID-Profile: Carla Meschini, Andrea Bartolucci, Ulysse Pereira

Förderung

  • Université de Technologie de Compiègne
  • Inserm
  • Biopredic (France)
  • Region des Hauts de France, Université de Technologie de Compiègne
  • DOT Chair—Disruptive Organoid Technologies against Metabolic Syndrome
  • Cryorg
  • European Union

Zitieren

APA

Meschini, C., Bartolucci, A., & Pereira, U. (2026). Comparative Evaluation of Freezing Protocols and Cryopreservation Media for the Preservation of Alginate Encapsulated HepaRG Cells. Cells. https://doi.org/10.3390/cells15191783

Vancouver

Meschini C, Bartolucci A, Pereira U. Comparative Evaluation of Freezing Protocols and Cryopreservation Media for the Preservation of Alginate Encapsulated HepaRG Cells. Cells. 2026. doi:10.3390/cells15191783

BibTeX
@article{Meschini2026,
  author = {Meschini, Carla and Bartolucci, Andrea and Pereira, Ulysse},
  title = {Comparative Evaluation of Freezing Protocols and Cryopreservation Media for the Preservation of Alginate Encapsulated HepaRG Cells},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191783}
}
Kostenlos starten →